A ARP PUBLIC POLICY INSTITUTE APRIL 2019 Rx Price Watch Price Decreases for Widely Used Generic Drugs Slow in 2017 after Two Years of Substantial Price Drops Stephen W. Schondelmeyer Leigh Purvis PRIME Institute, University of Minnesota AARP Public Policy Institute • Generic drugs have long been a means $365 in 2017. On average, older Americans of helping consumers and payers reduce take 4.5 prescription drugs every month. prescription drug costs, currently accounting Consequently, older adults who use generic for nearly 90 percent of all retail prescriptions prescription drugs are likely to have filled in the United States. experienced an average annual retail cost of • In 2017, retail prices for 390 widely used drug therapy of about $1,642 in 2017. generic prescription drugs fell by an average of — This amount is roughly 6 percent of the 9.3 percent. In contrast, the general inflation median income for Medicare beneficiaries. rate was 2.1 percent over the same period. — This followed two consecutive years (2015 • In 2017, the average annual price of therapy for widely used brand name prescription and 2016) of substantial generic drug price drugs was more than 18 times higher than decreases; the previous two consecutive the average annual price of therapy for years (2013 and 2014) saw increases in generic prescription drugs ($6,798 v. $365, generic drug prices. respectively). In 2013, the price differential • All but 3 of the 390 generic prescription drug between these same market baskets was products in the study’s market basket had a substantially smaller ($4,308 vs. $751, retail price change in 2017. respectively). — 297 drug products (76 percent) experienced a price decrease, and the remaining 90 • The availability of economically competitive and lower-cost generic drugs will take on added (23 percent) experienced a price increase. importance as more brand name drugs and • The average annual cost for a generic biologicals enter the market with unusually medication used on a chronic basis was high prices. A ARP PUBLIC POLICY INSTITUTE APRIL 2019 Average Annual Cost of Therapy for Widely Used Generic Drugs is More Than 18 Times Lower than Cost of Therapy for Widely Used Brand Name Drugs in 2017 Prepared by the AARP Public Policy Institute and the PRIME Institute, University of Minnesota, based on data from Truven Health MarketScan® Research Databases. Average Annual Generic Drug Price Decrease Slows in 2017 after Two Consecutive Years of Substantial Price Decreases © AARP PUBLIC POLICY INSTITUTE 601 E Street, NW Washington DC 20049 Follow us on Twitter @AARPpolicy on facebook.com/AARPpolicy www.aarp.org/ppi Full report available at http://www.aarp.org/rxpricewatch. For more reports from the Public Policy Note: Calculations of the average annual generic drug price change include the Institute, visit http://www.aarp.org/ppi/. 390 drug products most widely used by older Americans. Prepared by the AARP Public Policy Institute and the PRIME Institute, University of Minnesota, based on data from Truven Health MarketScan® Research Databases. 2